The hepatitis b vaccine is a vaccine against hepatitis b.That is, from hepatitis b virus carrier plasma isolation of hepatitis b surface antigen (HbsAg), after treatment and made.After second liver vaccine is inoculated, can stimulate immune system to produce protective antibody, this kind of antibody is in the humoral in the person, once second liver virus appears, antibody can act immediately, clear its, prevent infection, won't harm liver, make human body had the immunity that prevents second liver thereby.Therefore, hepatitis b vaccine has become an indispensable umbrella in life.Prevention generally lasts for at least 12 years, so there is no need for anti-hbs surveillance or enhanced immunity in the general population.However, anti-hbs surveillance can be carried out on high-risk groups, such as anti-hbs <10mIU/ml, which can be given enhanced immunity.
The global Recombinant Hepatitis B Vaccine market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
In terms of production side, this report researches the Recombinant Hepatitis B Vaccine production capacity, value, ex-factory price, growth rate, market share by manufacturers, regions (or countries) and by Type.
In terms of consumption side, this report focuses on the consumption of Recombinant Hepatitis B Vaccine by regions (countries) and by Application.
The global Recombinant Hepatitis B Vaccine market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Recombinant Hepatitis B Vaccine market. These figures have been provided in terms of both revenue and volume for the period 2016-2027. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise Recombinant Hepatitis B Vaccine markets such as North America, Europe, China and Japan, etc. Key regions covered in the report are U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE
For the period 2016-2027, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Recombinant Hepatitis B Vaccine market. For the period 2016-2021, it provides sales (consumption) analysis and forecast of different regional markets by each application as well as type segment in terms of volume.
Manufacturers
The report includes comprehensive company profiling of leading and emerging companies competing in the global Recombinant Hepatitis B Vaccine market. It provides a detailed list of players operating at a global level. The players have been listed according to the type of products they offer in the global Recombinant Hepatitis B Vaccine market and other factors. As part of the company profiling, the analysts authoring the report has provided the market entry year of each player considered for the research study. The report also offers extensive price, volume sales, and revenue analysis by the manufacturer at the global level for the period 2016-2021.
By Type and Application Segments
The report includes a detailed analysis of leading and type and application segments of the global Recombinant Hepatitis B Vaccine market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue sales analysis and forecast of the global Recombinant Hepatitis B Vaccine market by each type segment for the period 2016-2027. It also offers volume sales (consumption) analysis and forecast of the global Recombinant Hepatitis B Vaccine market by each type segment for the same period. Also, it provides volume sales (consumption) analysis and forecast of the global Recombinant Hepatitis B Vaccine market by each application segment for the same period.
This report includes the following manufacturers:
Merck
GlaxoSmithKline Plc
Pfizer Inc.
Sanofi Pasteur
CSL Limited
Emergent Biosolutions
Serum Institute of India
Johnson & Johnson
Hualan Biological Engineering
NCPC
China National Biotec Group
Dalian Hissen Bio-pharm
Beijing Tiantan Biological
Market Segment by Type
10mcg/ml
10mcg/0.5ml
Market Segment by Application
Newborn
Primary School Students
Adult
Research Methodology
To compile the detailed study of the global Recombinant Hepatitis B Vaccine market, a robust research methodology has been adopted that aids in determining the key insights and also evaluates the growth prospects of the Recombinant Hepatitis B Vaccine market. LBI Research analysts have conducted in-depth primary and secondary research to obtain crucial insights into the Recombinant Hepatitis B Vaccine market. To carry out secondary research, the analysts have collected the information through company annual reports, journals, company press releases, and paid databases that were referred to gain and identify better opportunities in the global market.
The global Recombinant Hepatitis B Vaccine market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
In terms of production side, this report researches the Recombinant Hepatitis B Vaccine production capacity, value, ex-factory price, growth rate, market share by manufacturers, regions (or countries) and by Type.
In terms of consumption side, this report focuses on the consumption of Recombinant Hepatitis B Vaccine by regions (countries) and by Application.
The global Recombinant Hepatitis B Vaccine market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Recombinant Hepatitis B Vaccine market. These figures have been provided in terms of both revenue and volume for the period 2016-2027. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise Recombinant Hepatitis B Vaccine markets such as North America, Europe, China and Japan, etc. Key regions covered in the report are U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE
For the period 2016-2027, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Recombinant Hepatitis B Vaccine market. For the period 2016-2021, it provides sales (consumption) analysis and forecast of different regional markets by each application as well as type segment in terms of volume.
Manufacturers
The report includes comprehensive company profiling of leading and emerging companies competing in the global Recombinant Hepatitis B Vaccine market. It provides a detailed list of players operating at a global level. The players have been listed according to the type of products they offer in the global Recombinant Hepatitis B Vaccine market and other factors. As part of the company profiling, the analysts authoring the report has provided the market entry year of each player considered for the research study. The report also offers extensive price, volume sales, and revenue analysis by the manufacturer at the global level for the period 2016-2021.
By Type and Application Segments
The report includes a detailed analysis of leading and type and application segments of the global Recombinant Hepatitis B Vaccine market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue sales analysis and forecast of the global Recombinant Hepatitis B Vaccine market by each type segment for the period 2016-2027. It also offers volume sales (consumption) analysis and forecast of the global Recombinant Hepatitis B Vaccine market by each type segment for the same period. Also, it provides volume sales (consumption) analysis and forecast of the global Recombinant Hepatitis B Vaccine market by each application segment for the same period.
This report includes the following manufacturers:
Merck
GlaxoSmithKline Plc
Pfizer Inc.
Sanofi Pasteur
CSL Limited
Emergent Biosolutions
Serum Institute of India
Johnson & Johnson
Hualan Biological Engineering
NCPC
China National Biotec Group
Dalian Hissen Bio-pharm
Beijing Tiantan Biological
Market Segment by Type
10mcg/ml
10mcg/0.5ml
Market Segment by Application
Newborn
Primary School Students
Adult
Research Methodology
To compile the detailed study of the global Recombinant Hepatitis B Vaccine market, a robust research methodology has been adopted that aids in determining the key insights and also evaluates the growth prospects of the Recombinant Hepatitis B Vaccine market. LBI Research analysts have conducted in-depth primary and secondary research to obtain crucial insights into the Recombinant Hepatitis B Vaccine market. To carry out secondary research, the analysts have collected the information through company annual reports, journals, company press releases, and paid databases that were referred to gain and identify better opportunities in the global market.
1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Recombinant Hepatitis B Vaccine Market Size Growth Rate by Type
1.2.2 10mcg/ml
1.2.3 10mcg/0.5ml
1.3 Market Segment by Application
1.3.1 Global Recombinant Hepatitis B Vaccine Market Share by Application (2016 VS 2021 VS 2027)
1.3.2 Newborn
1.3.3 Primary School Students
1.3.4 Adult
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Recombinant Hepatitis B Vaccine Market Size (2016-2027)
2.1.1 Global Recombinant Hepatitis B Vaccine Revenue (2016-2027)
2.1.2 Global Recombinant Hepatitis B Vaccine Sales (2016-2027)
2.2 Global Recombinant Hepatitis B Vaccine Market Size across Key Geographies Worldwide: 2016 VS 2021 VS 2027
2.2.1 Global Recombinant Hepatitis B Vaccine Sales by Regions (2016-2021)
2.2.2 Global Recombinant Hepatitis B Vaccine Revenue by Regions (2016-2021)
2.3 Global Recombinant Hepatitis B Vaccine Market Size Forecast by Region
2.3.1 Global Recombinant Hepatitis B Vaccine Sales Forecast by Region (2022-2027)
2.3.2 Global Recombinant Hepatitis B Vaccine Revenue Forecast by Region (2022-2027)
2.4 Global Top Recombinant Hepatitis B Vaccine Regions (Countries) Ranking by Market Size
2.5 Recombinant Hepatitis B Vaccine Industry Trends
2.5.1 Recombinant Hepatitis B Vaccine Market Trends
2.5.2 Recombinant Hepatitis B Vaccine Market Drivers
2.5.3 Recombinant Hepatitis B Vaccine Market Challenges
2.5.4 Recombinant Hepatitis B Vaccine Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Recombinant Hepatitis B Vaccine Manufacturers by Sales (2016-2021)
3.1.1 Global Recombinant Hepatitis B Vaccine Sales by Manufacturers (2016-2021)
3.1.2 Global Recombinant Hepatitis B Vaccine Sales Market Share by Manufacturers (2016-2021)
3.1.3 Global 5 and 10 Largest Manufacturers by Recombinant Hepatitis B Vaccine Sales in 2020
3.2 Global Top Manufacturers Recombinant Hepatitis B Vaccine by Revenue
3.2.1 Global Recombinant Hepatitis B Vaccine Revenue by Manufacturers (2016-2021)
3.2.2 Top Recombinant Hepatitis B Vaccine Manufacturers Covered: Ranking by Revenue
3.2.3 Global Recombinant Hepatitis B Vaccine Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Recombinant Hepatitis B Vaccine Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Recombinant Hepatitis B Vaccine as of 2020)
3.4 Global Recombinant Hepatitis B Vaccine Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Recombinant Hepatitis B Vaccine Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Recombinant Hepatitis B Vaccine Market
3.7 Key Manufacturers Recombinant Hepatitis B Vaccine Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Recombinant Hepatitis B Vaccine Market Size by Type
4.1 Global Recombinant Hepatitis B Vaccine Historic Market Review by Type (2016-2021)
4.1.1 Global Recombinant Hepatitis B Vaccine Sales Market Share by Type (2016-2021)
4.1.2 Global Recombinant Hepatitis B Vaccine Revenue Market Share by Type (2016-2021)
4.1.3 Recombinant Hepatitis B Vaccine Price by Type (2016-2021)
4.2 Global Recombinant Hepatitis B Vaccine Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Recombinant Hepatitis B Vaccine Sales Forecast by Type (2022-2027)
4.2.2 Global Recombinant Hepatitis B Vaccine Revenue Forecast by Type (2022-2027)
4.2.3 Recombinant Hepatitis B Vaccine Price Forecast by Type (2022-2027)
5 Global Recombinant Hepatitis B Vaccine Market Size by Application
5.1 Global Recombinant Hepatitis B Vaccine Historic Market Review by Application (2016-2021)
5.1.1 Global Recombinant Hepatitis B Vaccine Sales Market Share by Application (2016-2021)
5.1.2 Global Recombinant Hepatitis B Vaccine Revenue Market Share by Application (2016-2021)
5.1.3 Recombinant Hepatitis B Vaccine Price by Application (2016-2021)
5.2 Global Recombinant Hepatitis B Vaccine Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Recombinant Hepatitis B Vaccine Sales Forecast by Application (2022-2027)
5.2.2 Global Recombinant Hepatitis B Vaccine Revenue Forecast by Application (2022-2027)
5.2.3 Recombinant Hepatitis B Vaccine Price Forecast by Application (2022-2027)
6 North America
6.1 North America Recombinant Hepatitis B Vaccine Sales Breakdown by Company
6.1.1 North America Recombinant Hepatitis B Vaccine Sales by Company (2016-2027)
6.1.2 North America Recombinant Hepatitis B Vaccine Revenue by Company (2016-2027)
6.2 North America Recombinant Hepatitis B Vaccine Market Size by Type (2016-2027)
6.2.1 North America Recombinant Hepatitis B Vaccine Sales by Type (2016-2027)
6.2.2 North America Recombinant Hepatitis B Vaccine Revenue by Type (2016-2027)
6.3 North America Recombinant Hepatitis B Vaccine Market Size by Application (2016-2027)
6.3.1 North America Recombinant Hepatitis B Vaccine Sales by Application (2016-2027)
6.3.2 North America Recombinant Hepatitis B Vaccine Revenue by Application (2016-2027)
6.4 North America Recombinant Hepatitis B Vaccine Market Size by Country
6.4.1 North America Recombinant Hepatitis B Vaccine Sales by Country (2016-2027)
6.4.2 North America Recombinant Hepatitis B Vaccine Revenue by Country (2016-2027)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Recombinant Hepatitis B Vaccine Sales Breakdown by Company
7.1.1 Europe Recombinant Hepatitis B Vaccine Sales by Company (2016-2027)
7.1.2 Europe Recombinant Hepatitis B Vaccine Revenue by Company (2016-2027)
7.2 Europe Recombinant Hepatitis B Vaccine Market Size by Type (2016-2027)
7.2.1 Europe Recombinant Hepatitis B Vaccine Sales by Type (2016-2027)
7.2.2 Europe Recombinant Hepatitis B Vaccine Revenue by Type (2016-2027)
7.3 Europe Recombinant Hepatitis B Vaccine Market Size by Application (2016-2027)
7.3.1 Europe Recombinant Hepatitis B Vaccine Sales by Application (2016-2027)
7.3.2 Europe Recombinant Hepatitis B Vaccine Revenue by Application (2016-2027)
7.4 Europe Recombinant Hepatitis B Vaccine Market Size by Country
7.4.1 Europe Recombinant Hepatitis B Vaccine Sales by Country (2016-2027)
7.4.2 Europe Recombinant Hepatitis B Vaccine Revenue by Country (2016-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Recombinant Hepatitis B Vaccine Sales Breakdown by Company
8.1.1 Asia Pacific Recombinant Hepatitis B Vaccine Sales by Company (2016-2027)
8.1.2 Asia Pacific Recombinant Hepatitis B Vaccine Revenue by Company (2016-2027)
8.2 Asia Pacific Recombinant Hepatitis B Vaccine Market Size by Type (2016-2027)
8.2.1 Asia Pacific Recombinant Hepatitis B Vaccine Sales by Type (2016-2027)
8.2.2 Asia Pacific Recombinant Hepatitis B Vaccine Revenue by Type (2016-2027)
8.3 Asia Pacific Recombinant Hepatitis B Vaccine Market Size by Application (2016-2027)
8.3.1 Asia Pacific Recombinant Hepatitis B Vaccine Sales by Application (2016-2027)
8.3.2 Asia Pacific Recombinant Hepatitis B Vaccine Revenue by Application (2016-2027)
8.4 Asia Pacific Recombinant Hepatitis B Vaccine Market Size by Regions
8.4.1 Asia Pacific Recombinant Hepatitis B Vaccine Sales by Regions
8.4.2 Asia Pacific Recombinant Hepatitis B Vaccine Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Recombinant Hepatitis B Vaccine Sales Breakdown by Company
9.1.1 Latin America Recombinant Hepatitis B Vaccine Sales by Company (2016-2027)
9.1.2 Latin America Recombinant Hepatitis B Vaccine Revenue by Company (2016-2027)
9.2 Latin America Recombinant Hepatitis B Vaccine Market Size by Type (2016-2027)
9.2.1 Latin America Recombinant Hepatitis B Vaccine Sales by Type (2016-2027)
9.2.2 Latin America Recombinant Hepatitis B Vaccine Revenue by Type (2016-2027)
9.3 Latin America Recombinant Hepatitis B Vaccine Market Size by Application (2016-2027)
9.3.1 Latin America Recombinant Hepatitis B Vaccine Sales by Application (2016-2027)
9.3.2 Latin America Recombinant Hepatitis B Vaccine Revenue by Application (2016-2027)
9.4 Latin America Recombinant Hepatitis B Vaccine Market Size by Country
9.4.1 Latin America Recombinant Hepatitis B Vaccine Sales by Country (2016-2027)
9.4.2 Latin America Recombinant Hepatitis B Vaccine Revenue by Country (2016-2027)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Recombinant Hepatitis B Vaccine Sales Breakdown by Company
10.1.1 Middle East and Africa Recombinant Hepatitis B Vaccine Sales by Company (2016-2027)
10.1.2 Middle East and Africa Recombinant Hepatitis B Vaccine Revenue by Company (2016-2027)
10.2 Middle East and Africa Recombinant Hepatitis B Vaccine Market Size by Type (2016-2027)
10.2.1 Middle East and Africa Recombinant Hepatitis B Vaccine Sales by Type (2016-2027)
10.2.2 Middle East and Africa Recombinant Hepatitis B Vaccine Revenue by Type (2016-2027)
10.3 Middle East and Africa Recombinant Hepatitis B Vaccine Market Size by Application (2016-2027)
10.3.1 Middle East and Africa Recombinant Hepatitis B Vaccine Sales by Application (2016-2027)
10.3.2 Middle East and Africa Recombinant Hepatitis B Vaccine Revenue by Application (2016-2027)
10.4 Middle East and Africa Recombinant Hepatitis B Vaccine Market Size by Country
10.4.1 Middle East and Africa Recombinant Hepatitis B Vaccine Sales by Country (2016-2027)
10.4.2 Middle East and Africa Recombinant Hepatitis B Vaccine Revenue by Country (2016-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Company Profiles
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Overview
11.1.3 Merck Recombinant Hepatitis B Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.1.4 Merck Recombinant Hepatitis B Vaccine Products and Services
11.1.5 Merck Recombinant Hepatitis B Vaccine SWOT Analysis
11.1.6 Merck Recent Developments
11.2 GlaxoSmithKline Plc
11.2.1 GlaxoSmithKline Plc Corporation Information
11.2.2 GlaxoSmithKline Plc Overview
11.2.3 GlaxoSmithKline Plc Recombinant Hepatitis B Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.2.4 GlaxoSmithKline Plc Recombinant Hepatitis B Vaccine Products and Services
11.2.5 GlaxoSmithKline Plc Recombinant Hepatitis B Vaccine SWOT Analysis
11.2.6 GlaxoSmithKline Plc Recent Developments
11.3 Pfizer Inc.
11.3.1 Pfizer Inc. Corporation Information
11.3.2 Pfizer Inc. Overview
11.3.3 Pfizer Inc. Recombinant Hepatitis B Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.3.4 Pfizer Inc. Recombinant Hepatitis B Vaccine Products and Services
11.3.5 Pfizer Inc. Recombinant Hepatitis B Vaccine SWOT Analysis
11.3.6 Pfizer Inc. Recent Developments
11.4 Sanofi Pasteur
11.4.1 Sanofi Pasteur Corporation Information
11.4.2 Sanofi Pasteur Overview
11.4.3 Sanofi Pasteur Recombinant Hepatitis B Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.4.4 Sanofi Pasteur Recombinant Hepatitis B Vaccine Products and Services
11.4.5 Sanofi Pasteur Recombinant Hepatitis B Vaccine SWOT Analysis
11.4.6 Sanofi Pasteur Recent Developments
11.5 CSL Limited
11.5.1 CSL Limited Corporation Information
11.5.2 CSL Limited Overview
11.5.3 CSL Limited Recombinant Hepatitis B Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.5.4 CSL Limited Recombinant Hepatitis B Vaccine Products and Services
11.5.5 CSL Limited Recombinant Hepatitis B Vaccine SWOT Analysis
11.5.6 CSL Limited Recent Developments
11.6 Emergent Biosolutions
11.6.1 Emergent Biosolutions Corporation Information
11.6.2 Emergent Biosolutions Overview
11.6.3 Emergent Biosolutions Recombinant Hepatitis B Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.6.4 Emergent Biosolutions Recombinant Hepatitis B Vaccine Products and Services
11.6.5 Emergent Biosolutions Recombinant Hepatitis B Vaccine SWOT Analysis
11.6.6 Emergent Biosolutions Recent Developments
11.7 Serum Institute of India
11.7.1 Serum Institute of India Corporation Information
11.7.2 Serum Institute of India Overview
11.7.3 Serum Institute of India Recombinant Hepatitis B Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.7.4 Serum Institute of India Recombinant Hepatitis B Vaccine Products and Services
11.7.5 Serum Institute of India Recombinant Hepatitis B Vaccine SWOT Analysis
11.7.6 Serum Institute of India Recent Developments
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Corporation Information
11.8.2 Johnson & Johnson Overview
11.8.3 Johnson & Johnson Recombinant Hepatitis B Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.8.4 Johnson & Johnson Recombinant Hepatitis B Vaccine Products and Services
11.8.5 Johnson & Johnson Recombinant Hepatitis B Vaccine SWOT Analysis
11.8.6 Johnson & Johnson Recent Developments
11.9 Hualan Biological Engineering
11.9.1 Hualan Biological Engineering Corporation Information
11.9.2 Hualan Biological Engineering Overview
11.9.3 Hualan Biological Engineering Recombinant Hepatitis B Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.9.4 Hualan Biological Engineering Recombinant Hepatitis B Vaccine Products and Services
11.9.5 Hualan Biological Engineering Recombinant Hepatitis B Vaccine SWOT Analysis
11.9.6 Hualan Biological Engineering Recent Developments
11.10 NCPC
11.10.1 NCPC Corporation Information
11.10.2 NCPC Overview
11.10.3 NCPC Recombinant Hepatitis B Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.10.4 NCPC Recombinant Hepatitis B Vaccine Products and Services
11.10.5 NCPC Recombinant Hepatitis B Vaccine SWOT Analysis
11.10.6 NCPC Recent Developments
11.11 China National Biotec Group
11.11.1 China National Biotec Group Corporation Information
11.11.2 China National Biotec Group Overview
11.11.3 China National Biotec Group Recombinant Hepatitis B Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.11.4 China National Biotec Group Recombinant Hepatitis B Vaccine Products and Services
11.11.5 China National Biotec Group Recent Developments
11.12 Dalian Hissen Bio-pharm
11.12.1 Dalian Hissen Bio-pharm Corporation Information
11.12.2 Dalian Hissen Bio-pharm Overview
11.12.3 Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.12.4 Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Products and Services
11.12.5 Dalian Hissen Bio-pharm Recent Developments
11.13 Beijing Tiantan Biological
11.13.1 Beijing Tiantan Biological Corporation Information
11.13.2 Beijing Tiantan Biological Overview
11.13.3 Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.13.4 Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Products and Services
11.13.5 Beijing Tiantan Biological Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Recombinant Hepatitis B Vaccine Value Chain Analysis
12.2 Recombinant Hepatitis B Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Recombinant Hepatitis B Vaccine Production Mode & Process
12.4 Recombinant Hepatitis B Vaccine Sales and Marketing
12.4.1 Recombinant Hepatitis B Vaccine Sales Channels
12.4.2 Recombinant Hepatitis B Vaccine Distributors
12.5 Recombinant Hepatitis B Vaccine Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Recombinant Hepatitis B Vaccine Market Size Growth Rate by Type
1.2.2 10mcg/ml
1.2.3 10mcg/0.5ml
1.3 Market Segment by Application
1.3.1 Global Recombinant Hepatitis B Vaccine Market Share by Application (2016 VS 2021 VS 2027)
1.3.2 Newborn
1.3.3 Primary School Students
1.3.4 Adult
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Recombinant Hepatitis B Vaccine Market Size (2016-2027)
2.1.1 Global Recombinant Hepatitis B Vaccine Revenue (2016-2027)
2.1.2 Global Recombinant Hepatitis B Vaccine Sales (2016-2027)
2.2 Global Recombinant Hepatitis B Vaccine Market Size across Key Geographies Worldwide: 2016 VS 2021 VS 2027
2.2.1 Global Recombinant Hepatitis B Vaccine Sales by Regions (2016-2021)
2.2.2 Global Recombinant Hepatitis B Vaccine Revenue by Regions (2016-2021)
2.3 Global Recombinant Hepatitis B Vaccine Market Size Forecast by Region
2.3.1 Global Recombinant Hepatitis B Vaccine Sales Forecast by Region (2022-2027)
2.3.2 Global Recombinant Hepatitis B Vaccine Revenue Forecast by Region (2022-2027)
2.4 Global Top Recombinant Hepatitis B Vaccine Regions (Countries) Ranking by Market Size
2.5 Recombinant Hepatitis B Vaccine Industry Trends
2.5.1 Recombinant Hepatitis B Vaccine Market Trends
2.5.2 Recombinant Hepatitis B Vaccine Market Drivers
2.5.3 Recombinant Hepatitis B Vaccine Market Challenges
2.5.4 Recombinant Hepatitis B Vaccine Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Recombinant Hepatitis B Vaccine Manufacturers by Sales (2016-2021)
3.1.1 Global Recombinant Hepatitis B Vaccine Sales by Manufacturers (2016-2021)
3.1.2 Global Recombinant Hepatitis B Vaccine Sales Market Share by Manufacturers (2016-2021)
3.1.3 Global 5 and 10 Largest Manufacturers by Recombinant Hepatitis B Vaccine Sales in 2020
3.2 Global Top Manufacturers Recombinant Hepatitis B Vaccine by Revenue
3.2.1 Global Recombinant Hepatitis B Vaccine Revenue by Manufacturers (2016-2021)
3.2.2 Top Recombinant Hepatitis B Vaccine Manufacturers Covered: Ranking by Revenue
3.2.3 Global Recombinant Hepatitis B Vaccine Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Recombinant Hepatitis B Vaccine Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Recombinant Hepatitis B Vaccine as of 2020)
3.4 Global Recombinant Hepatitis B Vaccine Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Recombinant Hepatitis B Vaccine Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Recombinant Hepatitis B Vaccine Market
3.7 Key Manufacturers Recombinant Hepatitis B Vaccine Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Recombinant Hepatitis B Vaccine Market Size by Type
4.1 Global Recombinant Hepatitis B Vaccine Historic Market Review by Type (2016-2021)
4.1.1 Global Recombinant Hepatitis B Vaccine Sales Market Share by Type (2016-2021)
4.1.2 Global Recombinant Hepatitis B Vaccine Revenue Market Share by Type (2016-2021)
4.1.3 Recombinant Hepatitis B Vaccine Price by Type (2016-2021)
4.2 Global Recombinant Hepatitis B Vaccine Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Recombinant Hepatitis B Vaccine Sales Forecast by Type (2022-2027)
4.2.2 Global Recombinant Hepatitis B Vaccine Revenue Forecast by Type (2022-2027)
4.2.3 Recombinant Hepatitis B Vaccine Price Forecast by Type (2022-2027)
5 Global Recombinant Hepatitis B Vaccine Market Size by Application
5.1 Global Recombinant Hepatitis B Vaccine Historic Market Review by Application (2016-2021)
5.1.1 Global Recombinant Hepatitis B Vaccine Sales Market Share by Application (2016-2021)
5.1.2 Global Recombinant Hepatitis B Vaccine Revenue Market Share by Application (2016-2021)
5.1.3 Recombinant Hepatitis B Vaccine Price by Application (2016-2021)
5.2 Global Recombinant Hepatitis B Vaccine Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Recombinant Hepatitis B Vaccine Sales Forecast by Application (2022-2027)
5.2.2 Global Recombinant Hepatitis B Vaccine Revenue Forecast by Application (2022-2027)
5.2.3 Recombinant Hepatitis B Vaccine Price Forecast by Application (2022-2027)
6 North America
6.1 North America Recombinant Hepatitis B Vaccine Sales Breakdown by Company
6.1.1 North America Recombinant Hepatitis B Vaccine Sales by Company (2016-2027)
6.1.2 North America Recombinant Hepatitis B Vaccine Revenue by Company (2016-2027)
6.2 North America Recombinant Hepatitis B Vaccine Market Size by Type (2016-2027)
6.2.1 North America Recombinant Hepatitis B Vaccine Sales by Type (2016-2027)
6.2.2 North America Recombinant Hepatitis B Vaccine Revenue by Type (2016-2027)
6.3 North America Recombinant Hepatitis B Vaccine Market Size by Application (2016-2027)
6.3.1 North America Recombinant Hepatitis B Vaccine Sales by Application (2016-2027)
6.3.2 North America Recombinant Hepatitis B Vaccine Revenue by Application (2016-2027)
6.4 North America Recombinant Hepatitis B Vaccine Market Size by Country
6.4.1 North America Recombinant Hepatitis B Vaccine Sales by Country (2016-2027)
6.4.2 North America Recombinant Hepatitis B Vaccine Revenue by Country (2016-2027)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Recombinant Hepatitis B Vaccine Sales Breakdown by Company
7.1.1 Europe Recombinant Hepatitis B Vaccine Sales by Company (2016-2027)
7.1.2 Europe Recombinant Hepatitis B Vaccine Revenue by Company (2016-2027)
7.2 Europe Recombinant Hepatitis B Vaccine Market Size by Type (2016-2027)
7.2.1 Europe Recombinant Hepatitis B Vaccine Sales by Type (2016-2027)
7.2.2 Europe Recombinant Hepatitis B Vaccine Revenue by Type (2016-2027)
7.3 Europe Recombinant Hepatitis B Vaccine Market Size by Application (2016-2027)
7.3.1 Europe Recombinant Hepatitis B Vaccine Sales by Application (2016-2027)
7.3.2 Europe Recombinant Hepatitis B Vaccine Revenue by Application (2016-2027)
7.4 Europe Recombinant Hepatitis B Vaccine Market Size by Country
7.4.1 Europe Recombinant Hepatitis B Vaccine Sales by Country (2016-2027)
7.4.2 Europe Recombinant Hepatitis B Vaccine Revenue by Country (2016-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Recombinant Hepatitis B Vaccine Sales Breakdown by Company
8.1.1 Asia Pacific Recombinant Hepatitis B Vaccine Sales by Company (2016-2027)
8.1.2 Asia Pacific Recombinant Hepatitis B Vaccine Revenue by Company (2016-2027)
8.2 Asia Pacific Recombinant Hepatitis B Vaccine Market Size by Type (2016-2027)
8.2.1 Asia Pacific Recombinant Hepatitis B Vaccine Sales by Type (2016-2027)
8.2.2 Asia Pacific Recombinant Hepatitis B Vaccine Revenue by Type (2016-2027)
8.3 Asia Pacific Recombinant Hepatitis B Vaccine Market Size by Application (2016-2027)
8.3.1 Asia Pacific Recombinant Hepatitis B Vaccine Sales by Application (2016-2027)
8.3.2 Asia Pacific Recombinant Hepatitis B Vaccine Revenue by Application (2016-2027)
8.4 Asia Pacific Recombinant Hepatitis B Vaccine Market Size by Regions
8.4.1 Asia Pacific Recombinant Hepatitis B Vaccine Sales by Regions
8.4.2 Asia Pacific Recombinant Hepatitis B Vaccine Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Recombinant Hepatitis B Vaccine Sales Breakdown by Company
9.1.1 Latin America Recombinant Hepatitis B Vaccine Sales by Company (2016-2027)
9.1.2 Latin America Recombinant Hepatitis B Vaccine Revenue by Company (2016-2027)
9.2 Latin America Recombinant Hepatitis B Vaccine Market Size by Type (2016-2027)
9.2.1 Latin America Recombinant Hepatitis B Vaccine Sales by Type (2016-2027)
9.2.2 Latin America Recombinant Hepatitis B Vaccine Revenue by Type (2016-2027)
9.3 Latin America Recombinant Hepatitis B Vaccine Market Size by Application (2016-2027)
9.3.1 Latin America Recombinant Hepatitis B Vaccine Sales by Application (2016-2027)
9.3.2 Latin America Recombinant Hepatitis B Vaccine Revenue by Application (2016-2027)
9.4 Latin America Recombinant Hepatitis B Vaccine Market Size by Country
9.4.1 Latin America Recombinant Hepatitis B Vaccine Sales by Country (2016-2027)
9.4.2 Latin America Recombinant Hepatitis B Vaccine Revenue by Country (2016-2027)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Recombinant Hepatitis B Vaccine Sales Breakdown by Company
10.1.1 Middle East and Africa Recombinant Hepatitis B Vaccine Sales by Company (2016-2027)
10.1.2 Middle East and Africa Recombinant Hepatitis B Vaccine Revenue by Company (2016-2027)
10.2 Middle East and Africa Recombinant Hepatitis B Vaccine Market Size by Type (2016-2027)
10.2.1 Middle East and Africa Recombinant Hepatitis B Vaccine Sales by Type (2016-2027)
10.2.2 Middle East and Africa Recombinant Hepatitis B Vaccine Revenue by Type (2016-2027)
10.3 Middle East and Africa Recombinant Hepatitis B Vaccine Market Size by Application (2016-2027)
10.3.1 Middle East and Africa Recombinant Hepatitis B Vaccine Sales by Application (2016-2027)
10.3.2 Middle East and Africa Recombinant Hepatitis B Vaccine Revenue by Application (2016-2027)
10.4 Middle East and Africa Recombinant Hepatitis B Vaccine Market Size by Country
10.4.1 Middle East and Africa Recombinant Hepatitis B Vaccine Sales by Country (2016-2027)
10.4.2 Middle East and Africa Recombinant Hepatitis B Vaccine Revenue by Country (2016-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Company Profiles
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Overview
11.1.3 Merck Recombinant Hepatitis B Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.1.4 Merck Recombinant Hepatitis B Vaccine Products and Services
11.1.5 Merck Recombinant Hepatitis B Vaccine SWOT Analysis
11.1.6 Merck Recent Developments
11.2 GlaxoSmithKline Plc
11.2.1 GlaxoSmithKline Plc Corporation Information
11.2.2 GlaxoSmithKline Plc Overview
11.2.3 GlaxoSmithKline Plc Recombinant Hepatitis B Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.2.4 GlaxoSmithKline Plc Recombinant Hepatitis B Vaccine Products and Services
11.2.5 GlaxoSmithKline Plc Recombinant Hepatitis B Vaccine SWOT Analysis
11.2.6 GlaxoSmithKline Plc Recent Developments
11.3 Pfizer Inc.
11.3.1 Pfizer Inc. Corporation Information
11.3.2 Pfizer Inc. Overview
11.3.3 Pfizer Inc. Recombinant Hepatitis B Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.3.4 Pfizer Inc. Recombinant Hepatitis B Vaccine Products and Services
11.3.5 Pfizer Inc. Recombinant Hepatitis B Vaccine SWOT Analysis
11.3.6 Pfizer Inc. Recent Developments
11.4 Sanofi Pasteur
11.4.1 Sanofi Pasteur Corporation Information
11.4.2 Sanofi Pasteur Overview
11.4.3 Sanofi Pasteur Recombinant Hepatitis B Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.4.4 Sanofi Pasteur Recombinant Hepatitis B Vaccine Products and Services
11.4.5 Sanofi Pasteur Recombinant Hepatitis B Vaccine SWOT Analysis
11.4.6 Sanofi Pasteur Recent Developments
11.5 CSL Limited
11.5.1 CSL Limited Corporation Information
11.5.2 CSL Limited Overview
11.5.3 CSL Limited Recombinant Hepatitis B Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.5.4 CSL Limited Recombinant Hepatitis B Vaccine Products and Services
11.5.5 CSL Limited Recombinant Hepatitis B Vaccine SWOT Analysis
11.5.6 CSL Limited Recent Developments
11.6 Emergent Biosolutions
11.6.1 Emergent Biosolutions Corporation Information
11.6.2 Emergent Biosolutions Overview
11.6.3 Emergent Biosolutions Recombinant Hepatitis B Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.6.4 Emergent Biosolutions Recombinant Hepatitis B Vaccine Products and Services
11.6.5 Emergent Biosolutions Recombinant Hepatitis B Vaccine SWOT Analysis
11.6.6 Emergent Biosolutions Recent Developments
11.7 Serum Institute of India
11.7.1 Serum Institute of India Corporation Information
11.7.2 Serum Institute of India Overview
11.7.3 Serum Institute of India Recombinant Hepatitis B Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.7.4 Serum Institute of India Recombinant Hepatitis B Vaccine Products and Services
11.7.5 Serum Institute of India Recombinant Hepatitis B Vaccine SWOT Analysis
11.7.6 Serum Institute of India Recent Developments
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Corporation Information
11.8.2 Johnson & Johnson Overview
11.8.3 Johnson & Johnson Recombinant Hepatitis B Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.8.4 Johnson & Johnson Recombinant Hepatitis B Vaccine Products and Services
11.8.5 Johnson & Johnson Recombinant Hepatitis B Vaccine SWOT Analysis
11.8.6 Johnson & Johnson Recent Developments
11.9 Hualan Biological Engineering
11.9.1 Hualan Biological Engineering Corporation Information
11.9.2 Hualan Biological Engineering Overview
11.9.3 Hualan Biological Engineering Recombinant Hepatitis B Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.9.4 Hualan Biological Engineering Recombinant Hepatitis B Vaccine Products and Services
11.9.5 Hualan Biological Engineering Recombinant Hepatitis B Vaccine SWOT Analysis
11.9.6 Hualan Biological Engineering Recent Developments
11.10 NCPC
11.10.1 NCPC Corporation Information
11.10.2 NCPC Overview
11.10.3 NCPC Recombinant Hepatitis B Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.10.4 NCPC Recombinant Hepatitis B Vaccine Products and Services
11.10.5 NCPC Recombinant Hepatitis B Vaccine SWOT Analysis
11.10.6 NCPC Recent Developments
11.11 China National Biotec Group
11.11.1 China National Biotec Group Corporation Information
11.11.2 China National Biotec Group Overview
11.11.3 China National Biotec Group Recombinant Hepatitis B Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.11.4 China National Biotec Group Recombinant Hepatitis B Vaccine Products and Services
11.11.5 China National Biotec Group Recent Developments
11.12 Dalian Hissen Bio-pharm
11.12.1 Dalian Hissen Bio-pharm Corporation Information
11.12.2 Dalian Hissen Bio-pharm Overview
11.12.3 Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.12.4 Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Products and Services
11.12.5 Dalian Hissen Bio-pharm Recent Developments
11.13 Beijing Tiantan Biological
11.13.1 Beijing Tiantan Biological Corporation Information
11.13.2 Beijing Tiantan Biological Overview
11.13.3 Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.13.4 Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Products and Services
11.13.5 Beijing Tiantan Biological Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Recombinant Hepatitis B Vaccine Value Chain Analysis
12.2 Recombinant Hepatitis B Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Recombinant Hepatitis B Vaccine Production Mode & Process
12.4 Recombinant Hepatitis B Vaccine Sales and Marketing
12.4.1 Recombinant Hepatitis B Vaccine Sales Channels
12.4.2 Recombinant Hepatitis B Vaccine Distributors
12.5 Recombinant Hepatitis B Vaccine Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
